MAP kinases regulate involucrin gene expression

MAP 激酶调节外皮蛋白基因表达

基本信息

  • 批准号:
    7393200
  • 负责人:
  • 金额:
    $ 18.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-03-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

Involucrin is an important precursor of the keratinocyte cornified envelope. In epidermis, expression of involucrin protein and mRNA is keratinocyte-specific and differentiation-dependent (i.e., expression is confined to the suprabasal layers). Our transgenic mouse and cell culture studies show that the human involucrin (hINV) gene upstream regulatory region is sufficient for this expression and that specific DNA elements in this region bindAPI, C/EBP and Spl transcription factors to drive expression. During the past funding period we identified a novelPKC, Ras, MEKK1, MEK3 and p388-ERKl/2 signaling cascade that regulates the activity and level of API, Spl and C/EBP transcription factors to increase involucrin gene expression. Although identifying this cascade represents a major step forward in our understanding of differentiation associated gene regulation, our understanding of this signal transduction cascade is far from complete. Having established the importance of this pathway, we now propose experiments designed to extend these findings. Our studies show that novel PKC isoforms, including PKC5, are the major activators of hINV gene expression in normal keratinocytes and that differentiation agents trigger tyrosine phosphorylation of PKC8 to regulate gene expression. However, the importance of PKC8 tyrosine phosphorylation in keratinocytes is complicated, controversial, and has not been thoroughly studied. Our first major goal is to identify the role of tyrosine phosphorylation of PKC8 on PKC8 activity, subcellular localization, and ability to regulate downstream signaling events. An important observation is that signal transduction in normal human keratinocytes converges at the MAPK level on p388. Our preliminary studies suggest that differential interaction of MEK3 and MEK6 with p38S may function to regulate the balance between keratinocyte differentiation and apoptosis. The second major goal of this study is to characterize the role of these kinases in regulating the balance between differentiation and apoptosis. In particular, we will focus on the role of PKC8, MEK3 and p388 in regulating keratinocyte differentiation. The overall goal of this proposal is to expand our knowledge regarding the molecular mechanisms that drive differentiation in keratinocytes. This work is particularly important, as this mitogen-activated protein kinase (MAPK) signaling cascade has been implicated in regulating keratinocyte survival, differentiation, death, and transformation. It is hoped that a better understand of this cascade will lead to new and effective therapies for epidermal disease.
外膜蛋白是角质形成细胞外膜的重要前体。在表皮中,总苞蛋白的表达 蛋白质和mRNA是角质形成细胞特异性的和分化依赖性的(即,表达式仅限于 基底上层)。我们的转基因小鼠和细胞培养研究表明,人类外皮蛋白(hINV)基因 上游调控区足以用于该表达,且该区域中的特异性DNA元件结合API, C/EBP和Spl转录因子来驱动表达。在过去的资助期间,我们确定了一个新的PKC, Ras、MEKK 1、MEK 3和p388-ERK 1/2信号级联,其调节API、Sp1和 C/EBP转录因子增加外皮蛋白基因表达。虽然识别这种级联代表了一种 我们对分化相关基因调控的理解向前迈出了一大步,我们对这种信号的理解 转导级联还远未完成。在确定了这一途径的重要性之后,我们现在提出 旨在扩展这些发现的实验。我们的研究表明,新的PKC亚型,包括PKC 5,是 正常角质形成细胞中hINV基因表达的主要激活剂和分化剂触发酪氨酸 PKC 8磷酸化以调节基因表达。然而,PKC 8酪氨酸磷酸化的重要性, 角质形成细胞是复杂的、有争议的,并且尚未被彻底研究。我们的第一个主要目标是 PKC 8酪氨酸磷酸化对PKC 8活性、亚细胞定位和调控能力作用 下游信号事件。一个重要的观察是正常人角质形成细胞中的信号转导 在p388上收敛于MAPK水平。我们的初步研究表明,不同的相互作用MEK 3和 MEK 6与p38 S可能起调节角质形成细胞分化与凋亡之间的平衡的作用。的 本研究的第二个主要目标是描述这些激酶在调节 分化和凋亡。特别是,我们将重点关注PKC 8,MEK 3和p388在调节细胞凋亡中的作用。 角质形成细胞分化这项提案的总体目标是扩大我们对分子生物学的认识, 驱动角质形成细胞分化的机制。这项工作特别重要,因为这种丝裂原激活 蛋白激酶(MAPK)信号级联与调节角质形成细胞存活,分化, 死亡和转化人们希望,更好地了解这一级联反应将导致新的和有效的治疗方法 治疗表皮疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard L. Eckert其他文献

Delivery of growth factor to wounds using a genetically engineered biological bandage.
使用基因工程生物绷带将生长因子输送到伤口。
  • DOI:
    10.1002/jbm.820270911
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. A. Leyen;Daniel J. Smith;J. Bulgrin;Irwin A. Schafer;Richard L. Eckert
  • 通讯作者:
    Richard L. Eckert
2014 Annual Meeting of the Medical Dermatology Society
  • DOI:
    10.1038/jid.2014.168
  • 发表时间:
    2014-07-01
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Tiffany M. Scharadin;Richard L. Eckert
  • 通讯作者:
    Richard L. Eckert
The sequence of the human epidermal 58-kD (#5) type II keratin reveals an absence of 5' upstream sequence conservation between coexpressed epidermal keratins.
人表皮 58-kD 的序列(
  • DOI:
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richard L. Eckert;E. Rorke
  • 通讯作者:
    E. Rorke
Transcription factor regulation of epidermal keratinocyte gene expression
  • DOI:
    10.1007/bf00357073
  • 发表时间:
    1996-01-01
  • 期刊:
  • 影响因子:
    2.800
  • 作者:
    Richard L. Eckert;Jean F. Welter
  • 通讯作者:
    Jean F. Welter

Richard L. Eckert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard L. Eckert', 18)}}的其他基金

A novel sulforaphane cancer preventionmechanism
一种新型萝卜硫素癌症预防机制
  • 批准号:
    10335161
  • 财政年份:
    2018
  • 资助金额:
    $ 18.32万
  • 项目类别:
A novel sulforaphane cancer preventionmechanism
一种新型萝卜硫素癌症预防机制
  • 批准号:
    10088420
  • 财政年份:
    2018
  • 资助金额:
    $ 18.32万
  • 项目类别:
A novel sulforaphane cancer preventionmechanism
一种新型萝卜硫素癌症预防机制
  • 批准号:
    9754991
  • 财政年份:
    2018
  • 资助金额:
    $ 18.32万
  • 项目类别:
A novel sulforaphane cancer preventionmechanism
一种新型萝卜硫素癌症预防机制
  • 批准号:
    10524235
  • 财政年份:
    2018
  • 资助金额:
    $ 18.32万
  • 项目类别:
Stem Cells and Skin Cancer Prevention and Angiogenesis
干细胞和皮肤癌的预防和血管生成
  • 批准号:
    9248258
  • 财政年份:
    2015
  • 资助金额:
    $ 18.32万
  • 项目类别:
Stem Cells and Skin Cancer Prevention and Angiogenesis
干细胞和皮肤癌的预防和血管生成
  • 批准号:
    9045587
  • 财政年份:
    2015
  • 资助金额:
    $ 18.32万
  • 项目类别:
Keratoderma- an Exploratory Study
角化病——一项探索性研究
  • 批准号:
    8740156
  • 财政年份:
    2013
  • 资助金额:
    $ 18.32万
  • 项目类别:
Keratoderma- an Exploratory Study
角化病——一项探索性研究
  • 批准号:
    8588676
  • 财政年份:
    2013
  • 资助金额:
    $ 18.32万
  • 项目类别:
Polycomb genes and keratinocyte function
多梳基因和角质形成细胞功能
  • 批准号:
    7847204
  • 财政年份:
    2009
  • 资助金额:
    $ 18.32万
  • 项目类别:
Polycomb genes and keratinocyte function
多梳基因和角质形成细胞功能
  • 批准号:
    7900702
  • 财政年份:
    2009
  • 资助金额:
    $ 18.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了